文献速递性腺与生殖内分泌

健康女性、多囊卵巢综合征女性及下丘脑性闭经女性对曲普瑞林的内分泌反应

Endocrine Responses to Triptorelin in Healthy Women, Women With Polycystic Ovary Syndrome, and Women With Hypothalamic Amenorrhea.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

研究比较健康女性、多囊卵巢综合征(PCOS)及下丘脑性闭经(HA)女性对曲普瑞林的反应。研究1为前瞻性单盲安慰剂对照研究,曲普瑞林诱导各组LH升高幅度相似,但PCOS组FSH变化AUC较健康组和HA组衰减。研究2为回顾性分析,卵巢刺激后至少一个多囊形态卵巢的女性曲普瑞林后4小时FSH水平低于正常形态卵巢女性,AMH与FSH升高呈负相关。

要点

  • 曲普瑞林诱导的LH升高幅度在健康女性、PCOS女性及HA女性中相似。
  • PCOS女性FSH变化AUC较健康女性和HA女性衰减(P=0.0005)。
  • 卵巢刺激后,多囊形态卵巢女性曲普瑞林后4小时FSH低于正常形态卵巢女性。

核心结论

  • 曲普瑞林诱导的FSH反应在多囊卵巢女性中衰减,无论是否接受卵巢刺激,且与AMH水平呈负相关。

研究设计与样本

  • 研究1为前瞻性单盲安慰剂对照研究,在不进行卵巢刺激的情况下比较健康女性、PCOS女性和HA女性对曲普瑞林(0.2 mg)或生理盐水安慰剂的内分泌反应。
  • 研究2为回顾性分析,数据来自一项剂量探索随机对照试验,在卵巢刺激后的卵子捐赠周期中使用曲普瑞林(0.2-0.4 mg)。

主要发现

  • 研究1中,曲普瑞林诱导所有女性血清LH升高幅度相似(平均峰值LH:健康女性52.3 IU/L,PCOS女性46.2 IU/L,HA女性41.3 IU/L)。
  • 研究1中,PCOS女性血清FSH变化AUC较健康女性和HA女性衰减(血清FSH变化AUC中位数:PCOS 127.2 IU·h/L,健康女性253.8 IU·h/L,HA女性326.7 IU·h/L;P=0.0005)。
  • 研究2中,至少一个多囊形态卵巢的女性(n=60)曲普瑞林后4小时FSH水平低于正常形态卵巢女性(n=91)(34.0 vs 42.3 IU/L;P=0.0003)。
  • 无论是否接受卵巢刺激,血清抗苗勒管激素(AMH)均与曲普瑞林后FSH升高呈负相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Limited data exist regarding whether the endocrine response to the gonadotropin-releasing hormone receptor agonist (GnRHa) triptorelin differs in women with polycystic ovary syndrome (PCOS) compared with healthy women or those with hypothalamic amenorrhea (HA). OBJECTIVE: We compared the gonadotropin response to triptorelin in healthy women, women with PCOS, or those with HA without ovarian stimulation, and in women with or without polycystic ovaries undergoing oocyte donation cycles after ovarian stimulation. METHODS: The change in serum gonadotropin levels was determined in (1) a prospective single-blinded placebo-controlled study to determine the endocrine profile of triptorelin (0.2 mg) or saline-placebo in healthy women, women with PCOS, and those with HA, without ovarian stimulation; and (2) a retrospective analysis from a dose-finding randomized controlled trial of triptorelin (0.2-0.4 mg) in oocyte donation cycles after ovarian stimulation. RESULTS: In Study 1, triptorelin induced an increase in serum luteinizing hormone (LH) of similar amplitude in all women (mean peak LH: healthy, 52.3; PCOS, 46.2; HA, 41.3 IU/L). The AUC of change in serum follicle-stimulating hormone (FSH) was attenuated in women with PCOS compared with healthy women and women with HA (median AUC of change in serum FSH: PCOS, 127.2; healthy, 253.8; HA, 326.7 IU.h/L; P = 0.0005). In Study 2, FSH levels 4 hours after triptorelin were reduced in women with at least one polycystic morphology ovary (n = 60) vs normal morphology ovaries (n = 91) (34.0 vs 42.3 IU/L; P = 0.0003). Serum anti-Müllerian hormone (AMH) was negatively associated with the increase in FSH after triptorelin, both with and without ovarian stimulation. CONCLUSION: FSH response to triptorelin was attenuated in women with polycystic ovaries, both with and without ovarian stimulation, and was negatively related to AMH levels.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Abbara A, Phylactou M, Eng PC, et al. Endocrine Responses to Triptorelin in Healthy Women, Women With Polycystic Ovary Syndrome, and Women With Hypothalamic Amenorrhea. J Clin Endocrinol Metab. 2023. PMID: 36653328. doi:10.1210/clinem/dgad026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。